导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -11.78% | 855/1050 |
| 近一周 | -3.27% | 851/1104 |
| 近一月 | -6.90% | 812/1102 |
| 近一季 | -3.49% | 372/1092 |
| 近半年 | -12.70% | 838/1070 |
| 近一年 | -19.03% | 890/1018 |
| 近两年 | 8.05% | 846/926 |
| 近三年 | -15.66% | 756/834 |
| 成立以来 | -19.43% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.85% 758/1070 |
-7.64% 857/1101 |
- - |
- - |
| 2025 | 6.14% 867/1065 |
1.77% 662/1014 |
0.26% 662/1038 |
11.45% 827/1050 |
-6.67% 780/1065 |
| 2024 | -2.54% 646/1011 |
-2.70% 460/960 |
-2.60% 473/983 |
10.18% 609/991 |
-6.67% 763/1011 |
| 2023 | -19.67% 663/952 |
2.20% 498/880 |
-4.31% 482/895 |
-12.82% 715/915 |
-5.78% 588/952 |
| 2022 | -20.98% 367/867 |
-16.67% 344/773 |
4.07% 579/806 |
-11.84% 374/845 |
3.36% 267/867 |
| 2021 | -17.52% 526/740 |
-1.84% 218/580 |
2.89% 502/659 |
-15.01% 612/704 |
-3.90% 566/740 |
| 2020 | 46.72% 257/554 |
-1.41% 197/419 |
18.81% 306/466 |
12.38% 194/517 |
11.45% 312/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 招商核心优选股票C VS. 东吴新产业精选股票A(580008) |